HPCRF(HPCRF)
HPCRF
Q4 2026 EPS Estimate
$0.00
Nov 3, 2026
Revenue Estimate
$523M
FY2026E EPS$0.47
FY2027E EPS$0.49
No analyst ratings available
No analyst price targets available for HPCRF
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+3.67%
EPS+4.82%
FY2028
Rev+3.73%
EPS+5.06%
FY2029
Rev-0.97%
EPS-0.44%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $68.71B | $71.24B | $73.89B | $73.18B |
| Low | $67.13B | $68.61B | $71.67B | $70.97B |
| High | $70.21B | $74.88B | $76.61B | $75.86B |
| EBITDA Avg | $11.90B | $12.37B | $12.88B | $12.93B |
| Low | $11.60B | $12.06B | $12.56B | $12.61B |
| High | $12.26B | $12.75B | $13.28B | $13.33B |
| EBIT Avg | $8.22B | $8.59B | $8.99B | $8.95B |
| Low | $7.93B | $8.28B | $8.66B | $8.63B |
| High | $8.58B | $8.96B | $9.39B | $9.35B |
| Net Income Avg | $6.14B | $6.43B | $6.76B | $6.73B |
| Low | $5.90B | $6.18B | $6.49B | $6.46B |
| High | $6.43B | $6.74B | $7.08B | $7.05B |
| EPS Avg | $0.47 | $0.49 | $0.52 | $0.52 |
| Low | $0.45 | $0.47 | $0.50 | $0.50 |
| High | $0.49 | $0.52 | $0.54 | $0.54 |
| Analysts (Rev / EPS) | 15 / 1 | 16 / 1 | 13 / 1 | 14 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $17.36B | $17.36B |
| Low | $17.36B | $17.36B |
| High | $17.36B | $17.36B |
| EBITDA Avg | $2.54B | $3.19B |
| Low | $2.54B | $3.19B |
| High | $2.54B | $3.19B |
| EBIT Avg | $1.58B | $2.23B |
| Low | $1.58B | $2.23B |
| High | $1.58B | $2.23B |
| Net Income Avg | $1.14B | $1.67B |
| Low | $1.14B | $1.67B |
| High | $1.14B | $1.67B |
| EPS Avg | $0.09 | $0.13 |
| Low | $0.09 | $0.13 |
| High | $0.09 | $0.13 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions
